AH

Accord Healthcare at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Accord Healthcare takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 1018. Its program centres on choosing immunotherapy as a first-line treatment in lung cancer. It covers both extensive-stage small cell lung cancer and non-small cell lung cancer.

OrganizationESMO 2026 Attendance
AH
Accord Healthcare
Large pharmaExhibitor
Generic and biosimilar medicines company, part of India's Intas Pharmaceuticals, with a large oncology portfolio.
Booth
Exhibiting at Booth 1018
Satellite
Mon Oct 26
18:30–20:00
Accord Healthcare - Navigating immunotherapy options in first-line ES-SCLC and NSCLC
Sponsored session · with Henry Dunant Hospital Center
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Accord Healthcare

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction